505 related articles for article (PubMed ID: 27483290)
1. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH
Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290
[TBL] [Abstract][Full Text] [Related]
2. [Influence of poly-β-1-6-N-acetylglucosamine on biofilm formation and drug resistance of Acinetobacter baumannii].
Guo H; Xiang J
Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):45-7. PubMed ID: 25876639
[TBL] [Abstract][Full Text] [Related]
3. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
Duarte A; Ferreira S; Almeida S; Domingues FC
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
[TBL] [Abstract][Full Text] [Related]
4. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Tiwari V; Tiwari D; Patel V; Tiwari M
Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
[TBL] [Abstract][Full Text] [Related]
6. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production.
Perez LR
J Chemother; 2015 Feb; 27(1):13-6. PubMed ID: 24621167
[TBL] [Abstract][Full Text] [Related]
7. Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.
Kim HA; Ryu SY; Seo I; Suh SI; Suh MH; Baek WK
Microb Drug Resist; 2015 Aug; 21(4):452-7. PubMed ID: 25714496
[TBL] [Abstract][Full Text] [Related]
8. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.
Choi AH; Slamti L; Avci FY; Pier GB; Maira-Litrán T
J Bacteriol; 2009 Oct; 191(19):5953-63. PubMed ID: 19633088
[TBL] [Abstract][Full Text] [Related]
9. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development.
Saipriya K; Swathi CH; Ratnakar KS; Sritharan V
J Appl Microbiol; 2020 Jan; 128(1):15-27. PubMed ID: 31102552
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility.
Krzyściak P; Chmielarczyk A; Pobiega M; Romaniszyn D; Wójkowska-Mach J
APMIS; 2017 Nov; 125(11):1017-1026. PubMed ID: 28913903
[TBL] [Abstract][Full Text] [Related]
11. Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.
Sato Y; Unno Y; Ubagai T; Ono Y
PLoS One; 2018; 13(3):e0194556. PubMed ID: 29554105
[TBL] [Abstract][Full Text] [Related]
12. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.
He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G
Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730
[TBL] [Abstract][Full Text] [Related]
13. Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Kaliterna V; Kaliterna M; Hrenović J; Barišić Z; Tonkić M; Goic-Barisic I
Infect Dis (Lond); 2015; 47(12):902-7. PubMed ID: 26365683
[TBL] [Abstract][Full Text] [Related]
14. Activity of Norspermidine on Bacterial Biofilms of Multidrug-Resistant Clinical Isolates Associated with Persistent Extremity Wound Infections.
Cardile AP; Woodbury RL; Sanchez CJ; Becerra SC; Garcia RA; Mende K; Wenke JC; Akers KS
Adv Exp Med Biol; 2017; 973():53-70. PubMed ID: 27864804
[TBL] [Abstract][Full Text] [Related]
15. Biofilm inhibitory efficiency of phytol in combination with cefotaxime against nosocomial pathogen Acinetobacter baumannii.
Ramanathan S; Arunachalam K; Chandran S; Selvaraj R; Shunmugiah KP; Arumugam VR
J Appl Microbiol; 2018 Jul; 125(1):56-71. PubMed ID: 29473983
[TBL] [Abstract][Full Text] [Related]
16. Association of biofilm production with colonization among clinical isolates of
Ryu SY; Baek WK; Kim HA
Korean J Intern Med; 2017 Mar; 32(2):345-351. PubMed ID: 27653617
[TBL] [Abstract][Full Text] [Related]
17. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
[TBL] [Abstract][Full Text] [Related]
18. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
19. Multidrug Resistance Related to Biofilm Formation in Acinetobacter baumannii and Klebsiella pneumoniae Clinical Strains from Different Pulsotypes.
de Campos PA; Royer S; Batistão DW; Araújo BF; Queiroz LL; de Brito CS; Gontijo-Filho PP; Ribas RM
Curr Microbiol; 2016 May; 72(5):617-27. PubMed ID: 26846651
[TBL] [Abstract][Full Text] [Related]
20. [Current approaches to explain the virulence of Acinetobacter baumannii].
Aşık G
Mikrobiyol Bul; 2011 Apr; 45(2):371-80. PubMed ID: 21644082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
